Anteris Technologies (AVR) released 30-day clinical outcomes for the DurAVR THV in one hundred severe aortic stenosis patients with small aortic annuli – aortic annulus area 404 +/- 37mm2 -. The ...
The global PARADIGM Trial (ClinicalTrials.gov ID NCT07194265) is a prospective, randomized controlled trial (RCT) which will evaluate the safety and effectiveness of the DurAVR ® THV compared to ...
Researchers at KRISS observed water’s rapid freeze–melt cycles under ultrahigh pressure and discovered Ice XXI, the first new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback